Shao-Chun Chang
- Oncology top 2%
- Hepatology top 1%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Co-authors
- William DowhanPhilip HeacockEugenia MileykovskayaDennis R. VoelkerDo‐Youn OhYin YangWeijing SunDaniel J. Renouf
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (2 papers)Cellular transport and secretion (2 papers)Lipid metabolism and biosynthesis (2 papers)
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Lancet Oncology
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Shao-Chun Chang
7 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.2k
- Hepatology 676
- Molecular Biology 637
- Pulmonary and Respiratory Medicine 448
- Cancer Research 349
Countries citing papers authored by Shao-Chun Chang
This map shows the geographic impact of Shao-Chun Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao-Chun Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao-Chun Chang more than expected).
Fields of papers citing papers by Shao-Chun Chang
This network shows the impact of papers produced by Shao-Chun Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao-Chun Chang. The network helps show where Shao-Chun Chang may publish in the future.
Co-authorship network of co-authors of Shao-Chun Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Shao-Chun Chang. A scholar is included among the top collaborators of Shao-Chun Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao-Chun Chang. Shao-Chun Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinomabreakdown → | 480 |
| 2 | Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trialbreakdown → | 634 |
| 3 | Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 studybreakdown → | 652 |
| 4 | 46 | |
| 5 | 96 | |
| 6 | 80 | |
| 7 | 175 |
About Shao-Chun Chang
Shao-Chun Chang is a scholar working on Biochemistry, Hepatology and Cell Biology, having authored 7 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cellular transport and secretion (2 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Hepatology (676 citations), Oncology (1.2k citations) and Cancer Research (349 citations). Shao-Chun Chang has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include William Dowhan, Philip Heacock, Eugenia Mileykovskaya, Dennis R. Voelker, Do‐Youn Oh, Yin Yang, Weijing Sun, Daniel J. Renouf, Pilar García‐Alfonso and Allen Lee Cohn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.